junior bio above 50 ma in cloud good volume target 200 ma daily

see notes below-we like junior biotech's they outperform-fda approvals gives exclusivity-below radar-breakthrough tech in good demographic trends-fda approvals getting better leading to acquisitions-money flow growing-percent r uprer range-stoc about to cross in middle-mom strong dmi crossed